AI Article Synopsis
- This article reviews the 1-year results of a new intra-ocular implant called "Glauco-Claw" designed for patients with refractory chronic angle-closure glaucoma (ACG).
- The implant, made of polymethylmethacrylate, has a unique design that helps to prevent the reformation of goniosynechiae by tucking the peripheral iris into its claws, allowing for better eye pressure control.
- In a study involving five patients, all achieved and maintained targeted intra-ocular pressure without significant complications, with two patients not needing any anti-glaucoma medication.
Article Abstract
This article describes 1-year outcomes of a new intra-ocular implant, "Glauco-Claw," in refractory chronic angle-closure glaucoma (ACG). Glauco-Claw is a novice polymethylmethacrylate implant with a central ring and five claws placed circumferentially. It was placed in the anterior chamber and the peripheral iris was tucked into the claws, thus causing goniosynechialysis and preventing the reformation of goniosynechiae. It was implanted in five eyes of five patients, and they were followed up for 1 year. Target intra-ocular pressure was achieved and maintained in all the patients till the last follow-up. Two patients did not require any anti-glaucoma medication. No significant complications were observed in any patient. Glauco-Claw could be another armamentarium in the management of refractory chronic ACG.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491025 | PMC |
| http://dx.doi.org/10.4103/IJO.IJO_2678_22 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Glauco-Claw: A novice implant for chronic angle-closure glaucoma.
Indian J Ophthalmol
July 2023
Cornea and Anterior Segment Services, L J Eye Institute, Ambala, Haryana, India.
Article Synopsis
- This article reviews the 1-year results of a new intra-ocular implant called "Glauco-Claw" designed for patients with refractory chronic angle-closure glaucoma (ACG).
- The implant, made of polymethylmethacrylate, has a unique design that helps to prevent the reformation of goniosynechiae by tucking the peripheral iris into its claws, allowing for better eye pressure control.
- In a study involving five patients, all achieved and maintained targeted intra-ocular pressure without significant complications, with two patients not needing any anti-glaucoma medication.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!